期刊
JOURNAL OF CELLULAR PHYSIOLOGY
卷 236, 期 3, 页码 1776-1786出版社
WILEY
DOI: 10.1002/jcp.29953
关键词
BATF; JUN; IRF4 complex; interleukin-21; liver transplantation; T follicular helper; tacrolimus
资金
- Foundation of Southwest hospital [SWH2016JCYB-31, SWH2016JCYB-37]
- National Natural Science Foundation of China [81370573]
The study found that using Tacrolimus could prolong the survival of liver transplants and reduce inflammation injury. Tacrolimus inhibited the expression of the BATF/JUN/IRF4 complex and IL-21, participating in the inhibition of IL-21-producing Tfh cells. These findings suggest that the BATF/JUN/IRF4 complex-IL-21 axis may be a potential target for attenuating rejection injury after liver transplantation.
Rejection injury is a serious complication after liver transplantation (LTx). Tacrolimus (Tac) is a key immunosuppressive agent in the prevention of liver rejection after transplantation. The basic leucine zipper ATF-like transcription factor (BATF)/JUN/interferon regulatory factor 4 (IRF4) complex serves critical functions in the immune response. This study aimed to explore the role of the BATF/JUN/IRF4 complex in rejection after LTx by treatment with Tac. Herein, DA and Lewis (LEW) rats were used to construct the LTx animal model. The recipient LEW rats were treated with Tac or saline, subcutaneously. Splenic mononuclear cells were treated with Tac at 1 and 10 nM after stimulation with interleukin-6 (IL-6), and the expression of factors associated with the nuclear factor of activated T cells (NFAT)-BATF/JUN/IRF4 and IL-21 were detected. The results demonstrated that Tac prolonged the allografts survival and attenuated inflammation injury, and decreased the percentage frequencies of T follicular helper (Tfh) cells in peripheral blood mononuclear cells and inhibited B-cell lymphoma 6 (Bcl-6) and IL-6 expression in Tfh cells. In addition, Tac inhibited the expression of the BATF/JUN/IRF4 complex, Bcl-6 and IL-21 NFATc1 and NFATc2 were inhibited by Tac, and interacted with the promoter of BATF and IRF4. In conclusion, the attenuation of rejection injury may be dependent on the NFAT-BATF/JUN/IRF4-IL-21 axis, and the BATF/JUN/IRF4 complex participates in the inhibition of IL-21-producing Tfh cells after treatment with Tac. These findings suggest that the BATF/JUN/IRF4 complex-IL-21 axis may be used as a potential target for attenuating rejection injury after LTx.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据